Utility of therapeutic drug monitoring in the treatment of major depressive disorder
The utilization of TDM as a tool for treatment optimization in clinical routine with antidepressants for patients with MDD offers a valuable method to improve safety and effectiveness. This work summarizes essential TDM knowledge for antidepressants and encourages the application of TDM as part of the clinical decision-making process.
Authors
- Michael Paulzen (ORCID: https://orcid.org/0000-0003-4198-5160)
- Georgios Schoretsanitis (ORCID: https://orcid.org/0000-0002-3851-4117)
Institutions
- University of Zurich (CH)
- Centre for Mental Health (GB)
- University Hospital of Zurich (CH)
- Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US)
- Jülich Aachen Research Alliance (DE)
- Zucker Hillside Hospital (US)
- RWTH Aachen University (DE)
Publication Details
- Journal
- Current Opinion in Psychiatry
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1097/yco.0000000000001046
- Citations
- 1
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 1.39